XML 70 R54.htm IDEA: XBRL DOCUMENT v3.3.1.900
Acquisition of ALF-X Surgical Robotic System - Additional Information (Detail)
3 Months Ended 12 Months Ended
Sep. 21, 2015
USD ($)
shares
Dec. 31, 2015
USD ($)
Sep. 30, 2015
USD ($)
Jun. 30, 2015
USD ($)
Mar. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Sep. 30, 2014
USD ($)
Jun. 30, 2014
USD ($)
Mar. 31, 2014
USD ($)
Dec. 31, 2015
USD ($)
Dec. 31, 2014
USD ($)
Dec. 31, 2013
USD ($)
Sep. 21, 2015
EUR (€)
Business Acquisition [Line Items]                          
Securities consideration held in escrow percentage 10.00%                        
Escrow and security interest period 24 months                        
Intellectual property, net   $ 46,898,000       $ 2,241,000       $ 46,898,000 $ 2,241,000    
Legal, consulting and other costs related to acquisition   228,000 $ 4,003,000             4,231,000      
Revenues           134,000 $ 61,000 $ 113,000 $ 93,000   401,000 $ 1,431,000  
Net loss   13,579,000 $ 13,901,000 $ 9,348,000 $ 10,120,000 $ 8,079,000 $ 11,507,000 $ 10,587,000 $ 7,479,000 $ 46,948,000 $ 37,652,000 $ 28,358,000  
Minimum [Member]                          
Business Acquisition [Line Items]                          
Amortization period                   7 years      
Maximum [Member]                          
Business Acquisition [Line Items]                          
Amortization period                   10 years      
ALF-X Surgical Robotic System Acquisition [Member]                          
Business Acquisition [Line Items]                          
Common shares issued | shares 15,543,413                        
Cash consideration $ 25,000,000                        
Acquisition agreement, description                   The Lock-up Agreement provides that SOFAR may sell, transfer or convey (i) no more than 50% of the Securities Consideration during the period commencing on the one-year anniversary of the Closing Date and ending on the eighteen-month anniversary of the Closing Date; and (ii) no more than 75% of the Securities Consideration during the period commencing on the eighteen-month anniversary of the Closing Date and ending on the two-year anniversary of the Closing Date.      
Intellectual property, net $ 48,500,000                        
Amortization period 7 years                        
ALF-X Surgical Robotic System Acquisition [Member] | Maximum [Member] | Ending on Eighteen Month Anniversary [Member]                          
Business Acquisition [Line Items]                          
Percentage of securities consideration 50.00%                        
ALF-X Surgical Robotic System Acquisition [Member] | Maximum [Member] | Ending on Two Year Anniversary [Member]                          
Business Acquisition [Line Items]                          
Percentage of securities consideration 75.00%                        
ALF-X Surgical Robotic System Acquisition [Member] | U.S. Dollars [Member]                          
Business Acquisition [Line Items]                          
Cash consideration $ 25,000,000                        
ALF-X Surgical Robotic System Acquisition [Member] | Euro [Member]                          
Business Acquisition [Line Items]                          
Cash consideration payable | €                         € 27,500,000
ALF-X Surgical Robotic System Acquisition [Member] | First Tranche [Member]                          
Business Acquisition [Line Items]                          
Cash consideration 25,000,000                        
ALF-X Surgical Robotic System Acquisition [Member] | Third Tranche [Member]                          
Business Acquisition [Line Items]                          
Cash consideration payable | €                         15,000,000
ALF-X Surgical Robotic System Acquisition [Member] | Third Tranche [Member] | Minimum [Member]                          
Business Acquisition [Line Items]                          
Target revenue to be achieved | €                         25,000,000
ALF-X Surgical Robotic System Acquisition [Member] | Fourth Tranche [Member]                          
Business Acquisition [Line Items]                          
Cash consideration payable | €                         2,500,000
ALF-X Surgical Robotic System Acquisition [Member] | Second Tranche [Member]                          
Business Acquisition [Line Items]                          
Cash consideration payable | €                         € 10,000,000
Gross proceeds from financing $ 50,000,000                        
Interest rate 9.00%                       9.00%
ALF-X Surgical Robotic System Acquisition [Member] | Second Tranche [Member] | Minimum [Member]                          
Business Acquisition [Line Items]                          
Cash on hand $ 50,000,000                        
TransEnterix Italia [Member]                          
Business Acquisition [Line Items]                          
Membership interests percentage under Security agreement 10.00%                       10.00%
Legal, consulting and other costs related to acquisition                   $ 4,200,000      
Revenues   0                      
Net loss   $ 2,500,000